Soleus Capital Management, L.P. Staar Surgical CO Transaction History

Soleus Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $5.16 Million - $8.4 Million	110,200 New	110,200 $5.35 Million
Q2 2022 Aug 15, 2022	BUY	$50.24 - $80.48 $3.77 Million - $6.04 Million	75,094 New	75,094 $5.33 Million
Q2 2021 Aug 16, 2021	SELL	$105.76 - $154.96 $1.77 Million - $2.59 Million	-16,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $1.05 Million - $1.69 Million	13,400 Added 406.06%	16,700 $1.76 Million
Q4 2020 Feb 16, 2021	SELL	$55.93 - $82.78 $673,732 - $997,167	-12,046 Reduced 78.5%	3,300 $261,000
Q3 2020 Nov 13, 2020	SELL	$45.65 - $61.81 $231,993 - $314,118	-5,082 Reduced 24.88%	15,346 $868,000
Q2 2020 Aug 14, 2020	BUY	$29.15 - $61.54 $368,164 - $777,250	12,630 Added 161.96%	20,428 $1.26 Million
Q1 2020 May 15, 2020	SELL	$25.01 - $42.4 $703,831 - $1.19 Million	-28,142 Reduced 78.3%	7,798 $252,000
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $882,327 - $1.37 Million	35,940 New	35,940 $1.26 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.